Uricase with immunosuppressant combination

This page covers all Uricase with immunosuppressant combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Uric acid (via pegsiticase uricase enzyme).

Targets

Uric acid (via pegsiticase uricase enzyme)

Phase 3 pipeline (1)

• SEL-212 high-dose · Swedish Orphan Biovitrum · Rheumatology / Gout
  SEL-212 is a combination therapy that pairs a uricase enzyme with an immunosuppressant to lower uric acid levels while preventing immune reactions against the enzyme.

Patent intelligence

• uricase with immunosuppressant combination patent landscape — aggregated cliff calendar, attackable patents, originator estates